Orion price to free cash flow OEC

Market value divided by free cash flow over the last twelve months, since 2021.

Today, Oct 23, 2026: 12.1×
5-year median: 11.7×
Against its 5-year history: 52nd; percentile: 0 is its lowest day, 100 its highest
5-year range: 4.9× to 198×
Peer median: 25.7×

Orion's price to free cash flow is 12.1× as of Oct 23, 2026.

That is above its 5-year median of 11.7×, close to the middle of its last 5 years.

Over that time it ranged from 4.9× in Mar 2026 to 198× in Oct 2021.

The median for 10 chemicals stocks of a similar size is 25.7×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	12.1×	4.9×	16.0×
2025	8.5×	7.7×	8.7×
2024	90.8×	6.6×	110×
2023	8.3×	6.3×	9.5×
2022	74.8×	63.9×	74.8×
2021	69.9×	66.6×	198×

Against its peers

Companies in Chemicals nearest Orion's size, closest first, today.

Company	Price to free cash flow
OECOrion	12.1×
NAGENiagen Bioscience	n/m
FTKFlotek Industries	n/m
FTLFFitlife Brands	7.8×
CRONCronos	24.8×
ROGRogers	27.0×
NGVTIngevity	15.5×
IOSPInnospec	34.7×
BTMDbiote	1.9×
FULFuller H B	26.7×
WDFCWD 40	35.9×
Peer median	25.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Orion

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.